Angiostatin inhibits monocyte/macrophage migration via disruption of actin cytoskeleton

FASEB Journal

Volumn 21, Issue 14, 2007, Pages 3928-3936

  Perri, Sabrina R ^a   Annabi, Borhane ^b   Galipeau, Jacques ^a,c  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Actin disruption; TAMs; Tissue remodeling

Indexed keywords

ACTIN; ANGIOSTATIN; CASPASE; FLUOROCHROME; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHALLOIDIN; PLASMINOGEN; PROPIDIUM IODIDE; PROTEIN HK1 3; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL INFILTRATION; CELL MIGRATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSKELETON; FILOPODIUM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; LAMELLIPODIUM; MONOCYTE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ACTINS; ANGIOSTATINS; ANIMALS; CELL MIGRATION INHIBITION; CELLS, CULTURED; CYTOSKELETON; HUMANS; KRINGLES; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; MONOCYTES; NEOPLASMS, EXPERIMENTAL; PEPTIDE FRAGMENTS;

MURINAE;

EID: 36849018364     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.07-8158com     Document Type: Article

References (60)

1. Bolat, F., Kayaselcuk, F., Nursal, T. Z., Yagmurdur, M. C., Bal, N., and Demirhan, B. (2006) Microvessel density, VEGF expression, and tumor-associated macrophages in breast tumors: correlations with prognostic parameters. J. Exp. Clin. Cancer Res. 25, 365-372
2. Dirkx, A. E., Oude Egbrink, M. G., Wagstaff, J., and Griffioen, A. W. (2006) Monocyte/macrophage infiltration in tumors: modulators of angiogenesis. J. Leukoc. Biol. 80, 1183-1196
3. Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Okumura, H., Matsumoto, M., Miyazono, F., Hokita, S., and Aikou, T. (2003) Tumor-associated macrophage (TAM) infiltration in gastric cancer. Anticancer Res. 23, 4079-4083
4. Takanami, I., Takeuchi, K., and Kodaira, S. (1999) Tumor-associated macrophage infiltration in pulmonary adenocarcinoma: association with angiogenesis and poor prognosis. Oncology 57, 138-142
5. Mantovani, A., Allavena, P., and Sica, A. (2004) Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. Eur. J. Cancer 40, 1660-1667
6. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., and Hill, A. M. (2000) M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173
7. Bingle, L., Brown, N. J., and Lewis, C. E. (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J. Pathol. 196, 254-265
8. Leek, R. D., and Harris, A. L. (2002) Tumor-associated macrophages in breast cancer. J. Mammary Gland Biol. Neoplasia 7, 177-189
9. Oosterling, S. J., van der Bij, G. J., Meijer, G. A., Tuk, C. W., van Garderen, E., van Rooijen, N., Meijer, S., van der Sijp, J. R., Beelen, R. H., and van Egmond, M. (2005) Macrophages direct tumour histology and clinical outcome in a colon cancer model. J. Pathol. 207, 147-155
10. Sinha, P., Clements, V. K., and Ostrand-Rosenberg, S. (2005) Reduction of myeloid-derived suppressor cells and induction of M1 macrophages facilitate the rejection of established metastatic disease. J. Immunol. 174, 636-645
11. Barbera-Guillem, E., Nyhus, J. K., Wolford, C. C., Friece, C. R., and Sampsel, J. W. (2002) Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res. 62, 7042-7049
12. Lewis, C., and Murdoch, C. (2005) Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am. J. Pathol. 167, 627-635
13. Shimura, S., Yang, G., Ebara, S., Wheeler, T. M., Frolov, A., and Thompson, T. C. (2000) Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res. 60, 5857-5861
14. Condeelis, J., and Pollard, J. W. (2006) Macrophages obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266
15. Kusmartsev, S., and Gabrilovich, D. I. (2005) STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. J. Immunol. 174, 4880-4891
16. Saio, M., Radoja, S., Marino, M., and Frey, A. B. (2001) Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide. J. Immunol. 167, 5583-5593
17. Bottazzi, B., Polentarutti, N., Acero, R., Balsari, A., Boraschi, D., Ghezzi, P., Salmona, M., and Mantovani, A. (1983) Regulation of the macrophage content of neoplasms by chemoattractants. Science 220, 210-212
18. Mantovani, A. (1999) The chemokine system: redundancy for robust outputs. Immunol. Today 20, 254-257
19. Matsushima, K., Larsen, C. G., DuBois, G. C., and Oppenheim, J. J. (1999) Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med. 169, 1485-1490
20. Saji, H., Koike, M., Yamori, T., Saji, S., Seiki, M., Matsushima, K., and Toi, M. (2001) Significant correlation of monocyte chemoattractant protein-1 expression with neovascularization and progression of breast carcinoma. Cancer 92, 1085-1091
21. Yoshimura, T., Robinson, E. A., Tanaka, S., Appella, E., Kuratsu, J., and Leonard, E. J. (1989) Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants. J. Exp. Med. 169, 1449-1459
22. Azenshtein, E., Meshel, T., Shina, S., Barak, N., Keydar, I., and Ben-Baruch, A. (2005) A The angiogenic factors CXCL8 and VEGF in breast cancer: regulation by an array of pro-malignancy factors. Cancer Lett. 217, 73-86
23. Haghnegahdar, H., Du, J., Wang, D., Strieter, R. M., Burdick, M. D., Nanney, L. B., Cardwell, N., Luan, J., Shattuck-Brandt, R., and Richmond, A. (2000) The tumorigenic and angiogenic effects of MGSA/GRO proteins in melanoma. J. Leukoc. Biol. 67, 53-62
24. Payne, A. S., and Cornelius, L. A. (2002) The role of chemokines in melanoma tumor growth and metastasis. J. Invest Dermatol. 118, 915-922
25. Ueno, T., Toi, M., Saji, H., Muta, M., Bando, H., Kuroi, K., Koike, M., Inadera, H., and Matsushima, K. (2000) Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer. Clin. Cancer Res. 6, 3282-3289
26. Sica, A., Schioppa, T., Mantovani, A., and Allavena, P. (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer 42, 717-727
27. Knowles, H., Leek, R., and Harris, A. L. (2004) Macrophage infiltration and angiogenesis in human malignancy. Novartis Found. Symp. 256, 189-200
28. Pollard, J. W. (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78
29. Wyckoff, J., Wang, W., Lin, E. Y., Wang, Y., Pixley, F., Stanley, E. R., Graf, T., Pollard, J. W., Segall, J., and Condeelis, J. (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res. 64, 7022-7029
30. Perri, S. R., Nalbantoglu, J., Annabi, B., Koty, Z., Lejeune, L., Francois, M., Di Falco, M. R., Beliveau, R., and Galipeau, J. (2005) Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression. Cancer Res. 65, 8359-8365
31. Moulton, K. S., Vakili, K., Zurakowski, D., Soliman, M., Butterfield, C., Sylvin, E., Lo, K. M., Gillies, S., Javaherian, K., and Folkman, J. (2003) Inhibition of plaque neovascularization reduces macrophage accumulation and progression of advanced atherosclerosis. Proc. Natl. Acad. Sci. U. S. A. 100, 4736-4741
32. Evans, J. G., and Matsudaira, P. (2006) Structure and dynamics of macrophage podosomes. Eur. J. Cell Biol. 85, 145-149
33. Genersch, E., Hayess, K., Neuenfeld, Y., and Haller, H. (2000) Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and -independent pathways. J. Cell Sci. 113 Pt 23, 4319-4330
34. Myer, V. E., Fan, X. C., and Steitz, J. A. (1997) Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J. 16, 2130-2139
35. Akool, e-S., Kleinert, H., Hamada, F. M., Abdelwahab, M. H., Forstermann, U., Pfeilschifter, J., and Eberhardt, W. (2003) Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR. Mol. Cell. Biol. 23, 4901-4916
36. Annabi, B., Bouzeghrane, M., Currie, J. C., Dulude, H., Daigneault, L., Garde, S., Rabbani, S. A., Panchal, C., Wu, J. J., and Beliveau, R. (2006) Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling. Anticancer Drugs 17, 429-438
37. Huwiler, A., Akool, e-S., Aschrafi, A., Hamada, F. M., Pfeilschifter, J., and Eberhardt, W. (2003) ATP potentiates interleukin-1 beta-induced MMP-9 expression in mesangial cells via recruitment of the ELAV protein HuR. J. Biol. Chem. 278, 51758-51769
38. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (1994) Angiostatin. A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328
39. Kendall, R. L., and Thomas, K. A. (1993) Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. U. S. A. 90, 10705-10709
40. Peyruchaud, O., Serre, C. M., NicAmhlaoibh, R., Fournier, P., and Clezardin, P. (2003) Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity. J. Biol. Chem. 278, 45826-45832
41. Noonan, D. M., Brigati, C., Dell'eva, R., Morini, M., Minghelli, S., Benelli, R., and Albini, A. (2006) Regulation of angiogenesis by angiostatin through immune cells and IL 12 production. Retrovirology 3 Suppl. 1, S80
42. Cao, Y., Chen, A., An, S. S., Ji, R. W., Davidson, D., and Llinas, M. (1997) Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272, 22924-22928
43. Perri, S. R., Martineau D., Francois, M., Lejeune, L., Durocher, Y., and Galipeau, J. (2007) Plasminogen kringle 5 blocks tumor progression by anti-angiogenic and pro-inflammatory pathways. Mol. Cancer Ther. 6, 441-449
44. Benelli, R., Morini, M., Carrozzino, F., Ferrari, N., Minghelli, S., Santi, L., Cassatella, M., Noonan, D. M., and Albini, A. (2002) Neutrophils as a key cellular target for angiostatin: implications for regulation of angiogenesis and inflammation. FASEB J. 16, 267-269
45. Lucas, R., Holmgren, L., Garcia, I., Jimenez, B., Mandriota, S. J., Borlat, F., Sim, B. K., Wu, Z., Grau, G. E., Shing, Y., Soff, G. A., Bouck, N., and Pepper, M. S. (1998) Multiple forms of angiostatin induce apoptosis in endothelial cells. Blood 92, 4730-4741
46. Evans, J. G., Correia, I., Krasavina, O., Watson, N., and Matsudaira, P. (2003) Macrophage podosomes assemble at the leading lamella by growth and fragmentation. J. Cell Biol. 161, 697-705
47. Babb, S. G., Matsudaira, P., Sato, M., Correia, I., and Lim, S. S. (1997) Fimbrin in podosomes of monocyte-derived osteoclasts. Cell Motil. Cytoskeleton 37, 308-325
48. Linder, S., Hufner, K., Wintergerst, U., and Aepfelbacher, M. (2000) Microtubule-dependent formation of podosomal adhesion structures in primary human macrophages. J. Cell Sci. 113, 4165-4176
49. Wang, H., Doll, J. A., Jiang, K., Cundiff, D. L., Czarnecki, J. S., Wilson, M., Ridge, K. M., and Soff, G. A. (2006) Differential binding of plasminogen, plasmin, and angiostatin 4.5 to cell surface beta-actin: implications for cancer-mediated angiogenesis. Cancer Res. 66, 7211-7215
50. Dudani, A. K., Ben-Tchavtchavadze, M., Porter, S., and Tackaberry, E. (2005) Angiostatin and plasminogen share binding to endothelial cell surface actin. Biochem. Cell Biol. 83, 28-35
51. Troyanovsky, B., Levchenko, T., Mansson, G., Matvijenko, O., and Holmgren, L. (2001) Angiomotin. An angiostatin binding protein that regulates endothelial cell migration and tube formation. J. Cell Biol. 152, 1247-1254
52. Bratt, A., Birot, O., Sinha, I., Veitonmaki, N., Aase, K., Ernkvist, M., and Holmgren, L. (2005) Angiomotin regulates endothelial cell-cell junctions and cell motility. J. Biol. Chem. 280, 34859-34869
53. Ernkvist, M., Aase, K., Ukomadu, C., Wohlschlegel, J., Blackman, R., Veitonmaki, N., Bratt, A., Dutta, A., and Holmgren, L. (2006) p130-angiomotin associates to actin and controls endothelial cell shape. FASEB J 273, 2000-2011
54. Zetter, B. R. (2001) Hold that line. Angiomotin regulates endothelial cell motility. J. Cell Biol. 152, F35-F36
55. Dudani, A. K., Mehic, J., and Martyres, A. (2007) Plasminogen and angiostatin interact with heat shock proteins. Mol. Cell. Biochem. 300, 197-205
56. Kolaczkowska, E., Chadzinska, M., Scislowska-Czarnecka, A., Plytycz, B., Opdenakker, G., and Arnold, B. (2006) Gelatinase B/matrix metalloproteinase-9 contributes to cellular infiltration in a murine model of zymosan peritonitis. Immunobiology 211, 137-148
57. Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., and Shibuya, M. (2002) MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis. Cancer Cell 2, 289-300
58. Tomasek, J. J., Halliday, N. L., Updike, D. L., Ahern-Moore, J. S., Vu, T. K., Liu, R. W., and Howard, E. W. (1997) Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J. Biol. Chem. 272, 7482-7487
59. Lu, Y., and Wahl, L. M. (2005) Production of matrix metalloproteinase-9 by activated human monocytes involves a phosphatidylinositol-3 kinase/Akt/IKKalpha/NF-kappaB pathway. J. Leukoc. Biol. 78, 259-265
60. Mantovani, A. (2006) A macrophage diversity and polarization: in vivo veritas. Blood 108, 408-409